← Back to all trials
Recruiting
NCT05614583
Multidisciplinary Digital Therapeutics of Patellofemoral Pain Syndrome Versus Usual Care
Conditions: Patellofemoral Pain Syndrome
Sex: All
Ages: 19 Years – 50 Years
Phase: NA
Enrollment: 40
Sponsor: EverEx Inc.
Location: Korea, Republic of
Summary
This randomized controlled pilot study will be evaluating an app, MORT-PFPS app (ETH-01K), owned by EverEx, Inc., to examine safety and effectiveness in individuals with patellofemoral pain syndrome.
Eligibility Criteria
Inclusion Criteria:Male or female ≥ 19 and <50 years of agePatients who have a history of anterior knee pain in one or both knees, persisting for longer than 3months but not longer than 2 yearsPatients who have pain provoked by squattingPatients who have pain provoked by 2 or more following activitieslong sittingcyclingrunninggoing up or down stairskneelingcompression of the patellapalpation of the patellar facetsPatients who signed a written informed consent formExclusion Criteria:Patients with osteoarthritis which scored 2 or higher grade of the Kellgren-Lawrence scalePatients who have a history of knee pathologies or injuries (fracture, tendon injury, cartilage injury, or patella dislocation)Patients who had previous knee surgeriesPatients who have patellar tendinopathyPatients who have Osgood-Schlatter disease, or other defined pathological conditions of the kneePatients who are pregnant or breastfeedingPatients who are using anti-inflammatory medicationPatients with known substance/alcohol use disordersPatients with known somatic symptom and related disordersPatients who are not able to participate in an exercise or strengthening program
Source: ClinicalTrials.gov (NCT05614583). StuddyBuddy aggregates publicly available trial information.